XML 44 R29.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Restrictions on Cash and Cash Equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash within the consolidated balance sheets that sum to the total of the same on the consolidated statement of cash flows (in thousands):
December 31,
20242023
Cash and cash equivalents$161,435 $245,278 
Restricted cash6,137 6,142 
Total cash and cash equivalents and restricted cash$167,572 $251,420 
Schedule of Intangible Assets Estimated Useful Life
The Company’s intangible assets represent definite lived intangible assets, which are being amortized on a straight-line basis over their estimated useful lives as follows:
Customer relationships2 years
Trade names
2-9 years
Capitalized internal use software3 years
Software and technology
3-9 years
Schedule of Earnings per Share, Basic and Diluted
The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data):
Years Ended December 31,
202420232022
Basic loss per share:
Loss from continuing operations$(177,778)$(293,102)$(425,045)
Less: net loss attributable to non-controlling interest3,837 463 442 
Loss from continuing operations available to common shareholders(173,941)(292,639)(424,603)
Net income (loss) from discontinued operations, net of tax1,687 5,185 (136,874)
Net loss attributable to common shareholders$(172,254)$(287,454)$(561,477)
Shares used in computation:
Weighted-average common shares outstanding319,653,763 276,282,572 182,472,069 
Basic and diluted loss per share from continuing operations $(0.54)$(1.06)$(2.33)
Basic and diluted income (loss) per share from discontinued operations $— $0.02 $(0.75)
Basic and diluted loss per share$(0.54)$(1.04)$(3.08)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive:
December 31,
202420232022
Warrants to purchase common stock166,670 166,670 166,670 
Stock options18,749,529 19,028,904 15,517,069 
Unvested restricted stock units29,741,185 22,349,609 14,575,629 
Convertible notes variable settlement feature48,771,938 6,879,543 6,966,078 
Total97,429,322 48,424,726 37,225,446